☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Preconditioning Chemotherapy
Celyad Announces Successful Dosing of CYAD-01 IV in P-I THINK Trial for the Treatment of mCRC
September 5, 2018
Load more...
Back to Home